Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Medical Hypotheses, 3(64), p. 582-585

DOI: 10.1016/j.mehy.2004.07.028

Links

Tools

Export citation

Search in Google Scholar

Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction

Journal article published in 2005 by A. C. Mitsi, K. Hatzistergos, G. G. Baltogiannis, T. M. Kolettis ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Left ventricular (LV) remodeling after myocardial infarction (MI) may lead to congestive heart failure, disability and death. It consists of expansion of the infarct zone and dilatation of the non-infarcted myocardium, causing shape distortion and ventricular enlargement. Experimental studies have shown that treatment with growth hormone (GH) stimulates cardiac repair, resulting in increased infarct zone collagen scar formation and possibly enhanced proteinosynthesis. These actions may ameliorate the process of LV remodeling. We hypothesize that these beneficial effects may be more prominent, if GH is delivered selectively in the infarct area, during the early phase of acute MI. Experimental and clinical studies are necessary to validate this hypothesis.